论文部分内容阅读
目的:对经桡动脉与股动脉入径行冠状动脉动介入治疗的临床可行性、安全性及其疗效进行对比研究。方法:将92例随机分为TRA-pPCI组46例和TFA-pPCI组46例。结果:两组在桡/股动脉穿刺时间、指引导管置入时间、总PCI时程无明显差异,术后TFA-pPCI组出血、血栓/栓塞和血管并发症明显高于TRA-pPCI组。结论:TRA-pPCI有利于有效安全的抗凝治疗,可作为冠心病可选择的血管途径之一。
Objective: To compare the clinical feasibility, safety and efficacy of transradial and femoral artery approach coronary intervention. Methods: Ninety-two patients were randomly divided into TRA-pPCI group (46 cases) and TFA-pPCI group (46 cases). Results: There was no significant difference between the two groups in radial / femoral artery puncture time, catheterization time, and total PCI duration. The postoperative bleeding, thromboembolism and vascular complications in TFA-pPCI group were significantly higher than those in TRA-pPCI group. Conclusion: TRA-pPCI is an effective and safe anticoagulant therapy and may be used as one of the alternative vascular pathways for coronary heart disease.